AFMS on Tuesday published the effectiveness of the vaccine among healthcare providers and leaders of the Workers of Indian Armed Forces (VIN-WIN) in a study conducted by the Medical Journal of Armed Forces India.
The COVID-19 vaccine of the Serum India Institute provides 93% protection against coronavirus and reduces mortality by 98%, the institute said on Tuesday citing a study by the Armed Forces Medical Services (AFMC) study.
“It has shown a 93% reduction in infection during the second wave driven by the Delta divergence and reduced mortality by 98%,” he said.
Officially released, 1.59 million Health Care Workers and Armed Forces leaders were among the first to respond when India launched its COVID-19 vaccination campaign on January 16, 2021. The study was conducted mainly on healthy men and a few fatal diseases. . Children and the elderly were excluded.
How is the effectiveness of the vaccine calculated?
In the Vin-WIN study, the authors calculated the incidence rate and the incidence rate. Drug performance is calculated as the average for a single event. Both fixed adjusted values were measured and adjusted to the force of the epidemic, the second wave, and the variable numbers in the three groups daily. The study was obtained at no additional cost by analyzing the available data, such as the official release.
The VIN-WIN team study was made with anonymous data from the existing Armed Forces health monitoring system designed to monitor COVID-19. The monitoring program contains daily immunization information for first and second doses, dates for reliable mortality testing related to COVID-19 and COVID; which were analyzed, the official statement also said.
Emphasizing the importance of vaccines against COVID-19, Paul said the vaccine reduces infection but is not a complete guarantee.
“There is no vaccine that guarantees that infection will not occur but serious illnesses are preventable and almost eliminated. I urge you to be careful, cautious, have faith in our vaccines, and continue to be vigilant in the weeks and months to come.
About 88% of all antiretroviral drugs in India have so far been SII’s Covishield shot, a version of the AstraZeneca vaccine, reports Reuters.
The government expects the company to increase its assets of the Covishield vaccine by about 120 million in August from 100 million in June.
The study was conducted on 15 lakh doctors and senior staff of the Covishield-led AFMC. “There was a 93% protection (for the people in charge of Covishield) and this was in the middle of the second wave driven by the Delta division … and dropped by 98% of the population,” said Niti Aayog health expert, Dr. VK Paul. in death and infection.
However, he also pointed out that there is a need to adhere to Covid’s code of conduct as there is no single vaccine that can guarantee protection from infection. “There is no vaccine that guarantees that infection will not occur but serious illnesses are preventable and almost eliminated,” he said.
The Director-General, AFMS Surgeon Vice Admiral Rajat Datta, a renowned cardiologist and author of the study, said 1.59 million Healthcare Workers and armed leaders were among the first to be accepted when India launched its vaccination campaign against COVID- 19 January 16, 2021. The study was conducted mainly on healthy men with few debilitating diseases. Children and the elderly were excluded. In the Vin-WIN study, the authors calculated the incidence rate and the incidence rate. Drug performance is calculated as the average for a single event. Both fixed adjusted values were measured and adjusted to the force of the epidemic, the second wave, and the variable numbers in the three groups daily. The study was obtained at no additional cost by analyzing the available data.
DG AFMS revealed that the VIN-WIN group study was conducted with anonymous data from the existing Armed Forces health monitoring system improved to monitor COVID-19. The monitoring program contained daily immunization details for first and second doses, COVID-19 test dates and COVID-related deaths
Despite local and regional challenges, armed forces have been able to vaccinate more than 82 percent of the population since May 30, 2021. The study was conducted as a result of the cooperation of various AFMS structures. Armed Forces Medical College, Army, Navy, and Air Force paramedics have partnered with DG AFMS to complete the study.
Emphasizing that all the drugs available in India are effective against the Delta variant, officials said the Indian Council of Medical Research is also investigating its effectiveness against the Delta Plus variant and the results are being analyzed and will soon be distributed.
Last word:
Many COVID-19 drugs appear to be effective and safe. Two doses are recommended. However, further research is needed to investigate the long-term efficacy and safety of vaccines as well as the effect of dosage, age, and production process on protective performance.
